The Disrupt Stage is where many of the biggest conversations in technology happen, with a legacy that stretches back for more ...

I’ve been covering Android since 2023, when I joined Android Police, mostly focusing on AI and everything around Pixel and ...

Are you ready to laugh? This week's ABC news quiz features hilarious pranks from all over the world, plus a quote that could only come from right here at home. There's also a daring space rescue and a ...

It’s the 250th anniversary of the United States. What type of party would it be without food? While we’re all familiar with certain all-American fare—hot dogs, hamburgers, apple pie, barbecue—there ...

Create a professional email identity by setting up your custom email domain. This guide walks you through every step to get your personalized email address up and running. Creating your own email ...

I recently came across something rare and valuable online: a list of helpful, scientifically sound free quizzes that can help people understand themselves better. If that doesn’t sound like such a ...

Replimune (REPL) shares climbed more than 60% in the premarket on Friday after the company announced plans to resubmit a marketing application for its lead asset RP1 in the U.S., following its second ...

Every day we’re faced with a zillion small choices: Go to sleep early, or watch one more episode of that Netflix drama. Call an old friend to catch up, or cruise social media. Of course, no single ...

Tesla fans cheered the news that the Dutch vehicle authority, RDW, approved the Full Self-Driving software for use in the Netherlands as a driver assistance system. The European variant of the FSD ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news.

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...